BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11117569)

  • 1. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.
    Karasu Z; Gurakar A; Kerwin B; Hulagu S; Jazzar A; McFadden R; Nour B; Sebastian A; Cassidy F; Stokes K; Van Thiel DH; Wright H
    Dig Dis Sci; 2000 Oct; 45(10):1971-6. PubMed ID: 11117569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
    Jabbour N; Zajko A; Orons P; Irish W; Fung JJ; Selby RR
    Dig Dis Sci; 1998 Nov; 43(11):2459-62. PubMed ID: 9824134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.
    Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M
    Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study.
    Gschwantler M; Vavrik J; Gebauer A; Kriwanek S; Schrutka-Kölbl C; Fleischer J; Madani B; Brownstone E; Tscholakoff D; Weiss W
    J Hepatol; 1999 Feb; 30(2):254-9. PubMed ID: 10068105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.
    Massoud OI; Zein NN
    Gastroenterol Hepatol (N Y); 2017 May; 13(5):286-291. PubMed ID: 28656025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.
    Barney EJ; Little EC; Gerkin RD; Ramos AX; Kahn J; Wong M; Kolli G; Manch R
    Dig Dis Sci; 2012 Sep; 57(9):2430-7. PubMed ID: 22588242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Chen Y; Yang C; Huang S; Liu J; Wang Y; Zhou C; Li T; Wang C; Ju S; Bai Y; Yao W; Xiong B
    Sci Rep; 2023 Jan; 13(1):1633. PubMed ID: 36717590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism.
    Pursnani KG; Sillin LF; Kaplan DS
    Am J Surg; 1997 Mar; 173(3):169-73. PubMed ID: 9124620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of TIPS on Splenic Volume and Thrombocytopenia.
    Liu J; Ma J; Yang C; Ye T; Meng J; Shi Q; Xiong B
    AJR Am J Roentgenol; 2021 Mar; 216(3):698-703. PubMed ID: 33439047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
    Papp M; Mezei G; Udvardy M; Altorjay I
    Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS).
    Nolte W; Ehrenreich H; Wiltfang J; Pahl K; Unterberg K; Kamrowski-Kruck H; Schindler CG; Figulla HR; Buchwald AB; Hartmann H; Ramadori G
    Liver; 2000 Feb; 20(1):60-5. PubMed ID: 10726962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.
    Lawrence SP; Lezotte DC; Durham JD; Kumpe DA; Everson GT; Bilir BM
    Dig Dis Sci; 1995 Jul; 40(7):1575-80. PubMed ID: 7628285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.
    Zhao D; Zhang G; Wang M; Zhang C; Li J
    Clin Mol Hepatol; 2019 Jun; 25(2):210-217. PubMed ID: 30897897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?
    Peck-Radosavljevic M; Zacherl J; Meng YG; Pidlich J; Lipinski E; Längle F; Steininger R; Mühlbacher F; Gangl A
    J Hepatol; 1997 Jul; 27(1):127-31. PubMed ID: 9252085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Harmonic Elastography of the Liver is Sensitive to Intrahepatic Pressure Gradient and Liver Decompression after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation.
    Tzschätzsch H; Sack I; Marticorena Garcia SR; Ipek-Ugay S; Braun J; Hamm B; Althoff CE
    Ultrasound Med Biol; 2017 Mar; 43(3):595-600. PubMed ID: 27979668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Bucsics T; Lampichler K; Vierziger C; Schoder M; Wolf F; Bauer D; Simbrunner B; Hartl L; Jachs M; Scheiner B; Trauner M; Gruenberger T; Karnel F; Mandorfer M; Reiberger T
    Dig Dis Sci; 2022 Dec; 67(12):5693-5703. PubMed ID: 35301618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.
    Saugel B; Mair S; Meidert AS; Phillip V; Messer M; Nennstiel S; Berger H; Gaa J; Wagner JY; Schneider H; Schmid RM; Huber W
    J Crit Care; 2014 Dec; 29(6):1001-5. PubMed ID: 25220530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.